Receipt of R&D tax credit
In brief · summary, not quotable
Genedrive plc has received an R&D tax credit refund of approximately £0.76 million from HMRC, covering the financial years ending 30 June 2024 and 30 June 2025. This significant cash inflow is expected to positively impact the company's financial position.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your GDR notes
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, confirms it has received an R&D tax credit refund of approximately £0.76m from HMRC in respect of the financial years ended 30 June 2024 and 30 June 2025.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.